Philip Morris Products S.A.
Clinical trials sponsored by Philip Morris Products S.A., explained in plain language.
Tobacco company developing and selling reduced-risk nicotine products.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
-
COPD patients may breathe easier by switching to heated tobacco
Symptom relief OngoingThis study looks at whether people with COPD and chronic bronchitis who switch from regular cigarettes to a tobacco heating system feel better and breathe easier. About 290 adults aged 40 and older who have smoked for at least 10 years will take part. Researchers will measure cou…
Sponsor: Philip Morris Products S.A. • Aim: Symptom relief
Last updated Sep 02, 2026 00:00 UTC
-
Heated tobacco study: can it cut cigarette toxins?
Knowledge-focused OngoingThis study looks at whether adult smokers who switch to a heated tobacco device (called THS or TP18) have lower levels of harmful chemicals in their body compared to those who keep smoking regular cigarettes. About 108 smokers will be monitored over a week in a clinic and then at…
Sponsor: Philip Morris Products S.A. • Aim: Knowledge-focused
Last updated Aug 01, 2026 00:00 UTC